Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Oct;33(10):2624–2630. doi: 10.1128/jcm.33.10.2624-2630.1995

Characterization of Newcastle disease virus isolates by reverse transcription PCR coupled to direct nucleotide sequencing and development of sequence database for pathotype prediction and molecular epidemiological analysis.

B S Seal 1, D J King 1, J D Bennett 1
PMCID: PMC228544  PMID: 8567895

Abstract

Degenerate oligonucleotide primers were synthesized to amplify nucleotide sequences from portions of the fusion protein and matrix protein genes of Newcastle disease virus (NDV) genomic RNA that could be used diagnostically. These primers were used in a single-tube reverse transcription PCR of NDV genomic RNA coupled to direct nucleotide sequencing of the amplified product to characterize more than 30 NDV isolates. In agreement with previous reports, differences in the fusion protein cleavage sequence that correlated genotypically with virulence among various NDV pathotypes were detected. By using sequences generated from the matrix protein gene coding for the nuclear localization signal, lentogenic viruses were again grouped phylogenetically separate from other pathotypes. These techniques were applied to compare neurotropic velogenic viruses isolated from an outbreak of Newcastle disease in cormorants and turkeys. Cormorant NDV isolates and an NDV isolate from an infected turkey flock in North Dakota had the fusion protein cleavage sequence 109SRGRRQKRFVG119. The R-for-G substitution at position 110 may be unique for the cormorant-type isolates. Although the amino acid sequences from the fusion protein cleavage site were identical, nucleotide sequence data correlate the outbreak in turkeys to a cormorant virus isolate from Minnesota and not to a cormorant virus isolate from Michigan. On the basis of sequence information, the cormorant isolates are virulent viruses related to isolates of psittacine origin, possibly genotypically distinct from other velogenic NDV isolates. These techniques can be used reliably for Newcastle disease epidemiology and for prediction of pathotypes of NDV isolates without traditional live-bird inoculations.

Full Text

The Full Text of this article is available as a PDF (207.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander D. J., Campbell G., Manvell R. J., Collins M. S., Parsons G., McNulty M. S. Characterisation of an antigenically unusual virus responsible for two outbreaks of Newcastle disease in the Republic of Ireland in 1990. Vet Rec. 1992 Jan 25;130(4):65–68. doi: 10.1136/vr.130.4.65. [DOI] [PubMed] [Google Scholar]
  2. Alexander D. J., Parsons G. Avian paramyxovirus type 1 infections of racing pigeons: 2 pathogenicity experiments in pigeons and chickens. Vet Rec. 1984 May 12;114(19):466–469. doi: 10.1136/vr.114.19.466. [DOI] [PubMed] [Google Scholar]
  3. Banerjee M., Reed W. M., Fitzgerald S. D., Panigraphy B. Neurotropic velogenic Newcastle disease in cormorants in Michigan: pathology and virus characterization. Avian Dis. 1994 Oct-Dec;38(4):873–878. [PubMed] [Google Scholar]
  4. Brugh M., Beard C. W. Atypical disease produced in chickens by Newcastle disease virus isolated from exotic birds. Avian Dis. 1984 Apr-Jun;28(2):482–488. [PubMed] [Google Scholar]
  5. Bruning-Fann C., Kaneene J., Heamon J. Investigation of an outbreak of velogenic viscerotropic Newcastle disease in pet birds in Michigan, Indiana, Illinois, and Texas. J Am Vet Med Assoc. 1992 Dec 1;201(11):1709–1714. [PubMed] [Google Scholar]
  6. Chambers P., Millar N. S., Emmerson P. T. Nucleotide sequence of the gene encoding the fusion glycoprotein of Newcastle disease virus. J Gen Virol. 1986 Dec;67(Pt 12):2685–2694. doi: 10.1099/0022-1317-67-12-2685. [DOI] [PubMed] [Google Scholar]
  7. Chambers P., Millar N. S., Platt S. G., Emmerson P. T. Nucleotide sequence of the gene encoding the matrix protein of Newcastle disease virus. Nucleic Acids Res. 1986 Nov 25;14(22):9051–9061. doi: 10.1093/nar/14.22.9051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Coleman N. A., Peeples M. E. The matrix protein of Newcastle disease virus localizes to the nucleus via a bipartite nuclear localization signal. Virology. 1993 Aug;195(2):596–607. doi: 10.1006/viro.1993.1411. [DOI] [PubMed] [Google Scholar]
  10. Collins M. S., Alexander D. J., Brockman S., Kemp P. A., Manvell R. J. Evaluation of mouse monoclonal antibodies raised against an isolate of the variant avian paramyxovirus type 1 responsible for the current panzootic in pigeons. Arch Virol. 1989;104(1-2):53–61. doi: 10.1007/BF01313807. [DOI] [PubMed] [Google Scholar]
  11. Collins M. S., Bashiruddin J. B., Alexander D. J. Deduced amino acid sequences at the fusion protein cleavage site of Newcastle disease viruses showing variation in antigenicity and pathogenicity. Arch Virol. 1993;128(3-4):363–370. doi: 10.1007/BF01309446. [DOI] [PubMed] [Google Scholar]
  12. French E. L., St George T. D., Percy J. J. Infection of chicks with recently isolated Newcastle disease viruses of low virulence. Aust Vet J. 1967 Sep;43(9):404–409. doi: 10.1111/j.1751-0813.1967.tb04895.x. [DOI] [PubMed] [Google Scholar]
  13. Glickman R. L., Syddall R. J., Iorio R. M., Sheehan J. P., Bratt M. A. Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J Virol. 1988 Jan;62(1):354–356. doi: 10.1128/jvi.62.1.354-356.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goldhaft T. M. Historical note on the origin of the LaSota strain of Newcastle disease virus. Avian Dis. 1980 Apr-Jun;24(2):297–301. [PubMed] [Google Scholar]
  15. Gotoh B., Ohnishi Y., Inocencio N. M., Esaki E., Nakayama K., Barr P. J., Thomas G., Nagai Y. Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J Virol. 1992 Nov;66(11):6391–6397. doi: 10.1128/jvi.66.11.6391-6397.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Iorio R. M., Syddall R. J., Sheehan J. P., Bratt M. A., Glickman R. L., Riel A. M. Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition. J Virol. 1991 Sep;65(9):4999–5006. doi: 10.1128/jvi.65.9.4999-5006.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jarecki-Black J. C., Bennett J. D., Palmieri S. A novel oligonucleotide probe for the detection of Newcastle disease virus. Avian Dis. 1992 Jan-Mar;36(1):134–138. [PubMed] [Google Scholar]
  18. Jarecki-Black J. C., King D. J. An oligonucleotide probe that distinguishes isolates of low virulence from the more pathogenic strains of Newcastle disease virus. Avian Dis. 1993 Jul-Sep;37(3):724–730. [PubMed] [Google Scholar]
  19. Jestin V., Cherbonnel M., L'Hospitalier R., Bennejean G. An ELISA blocking test using a peroxidase-labelled anti-HN monoclonal antibody for the specific titration of antibodies to avian paramyxovirus type 1 (PMV1). Arch Virol. 1989;105(3-4):199–208. doi: 10.1007/BF01311357. [DOI] [PubMed] [Google Scholar]
  20. Jestin V., Jestin A. Detection of Newcastle disease virus RNA in infected allantoic fluids by in vitro enzymatic amplification (PCR). Arch Virol. 1991;118(3-4):151–161. doi: 10.1007/BF01314026. [DOI] [PubMed] [Google Scholar]
  21. Kaleta E. F., Siegmann O., Jank-Ladwig R., Glünder G. Isolation and biological properties of virulent subpopulations from lentogenic Newcastle disease virus strains. Comp Immunol Microbiol Infect Dis. 1979;2(4):485–496. doi: 10.1016/0147-9571(79)90090-0. [DOI] [PubMed] [Google Scholar]
  22. King D. J. Newcastle disease virus passage in MDBK cells as an aid in detection of a virulent subpopulation. Avian Dis. 1993 Oct-Dec;37(4):961–969. [PubMed] [Google Scholar]
  23. Kotewicz M. L., Sampson C. M., D'Alessio J. M., Gerard G. F. Isolation of cloned Moloney murine leukemia virus reverse transcriptase lacking ribonuclease H activity. Nucleic Acids Res. 1988 Jan 11;16(1):265–277. doi: 10.1093/nar/16.1.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kwon H. M., Jackwood M. W., Gelb J., Jr Differentiation of infectious bronchitis virus serotypes using polymerase chain reaction and restriction fragment length polymorphism analysis. Avian Dis. 1993 Jan-Mar;37(1):194–202. [PubMed] [Google Scholar]
  25. Lana D. P., Snyder D. B., King D. J., Marquardt W. W. Characterization of a battery of monoclonal antibodies for differentiation of Newcastle disease virus and pigeon paramyxovirus-1 strains. Avian Dis. 1988 Apr-Jun;32(2):273–281. [PubMed] [Google Scholar]
  26. Le L., Brasseur R., Wemers C., Meulemans G., Burny A. Fusion (F) protein gene of Newcastle disease virus: sequence and hydrophobicity comparative analysis between virulent and avirulent strains. Virus Genes. 1988 Jul;1(4):333–350. doi: 10.1007/BF00257097. [DOI] [PubMed] [Google Scholar]
  27. Lewis J. G., Chang G. J., Lanciotti R. S., Trent D. W. Direct sequencing of large flavivirus PCR products for analysis of genome variation and molecular epidemiological investigations. J Virol Methods. 1992 Jul;38(1):11–23. doi: 10.1016/0166-0934(92)90165-a. [DOI] [PubMed] [Google Scholar]
  28. McGinnes L. W., Morrison T. G. Nucleotide sequence of the gene encoding the Newcastle disease virus fusion protein and comparisons of paramyxovirus fusion protein sequences. Virus Res. 1986 Sep;5(4):343–356. doi: 10.1016/0168-1702(86)90028-6. [DOI] [PubMed] [Google Scholar]
  29. McGinnes L. W., Morrison T. G. The nucleotide sequence of the gene encoding the Newcastle disease virus membrane protein and comparisons of membrane protein sequences. Virology. 1987 Feb;156(2):221–228. doi: 10.1016/0042-6822(87)90401-6. [DOI] [PubMed] [Google Scholar]
  30. McMillan B. C., Hanson R. P. Differentiation of exotic strains of Newcastle disease virus by oligonucleotide fingerprinting. Avian Dis. 1982 Apr-Jun;26(2):332–339. [PubMed] [Google Scholar]
  31. Miers L. A., Bankowski R. A., Zee Y. C. Optimizing the enzyme-linked immunosorbent assay for evaluating immunity of chickens to Newcastle disease. Avian Dis. 1983 Oct-Dec;27(4):1112–1125. [PubMed] [Google Scholar]
  32. Millar N. S., Chambers P., Emmerson P. T. Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains. J Gen Virol. 1988 Mar;69(Pt 3):613–620. doi: 10.1099/0022-1317-69-3-613. [DOI] [PubMed] [Google Scholar]
  33. Nagai Y., Klenk H. D., Rott R. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology. 1976 Jul 15;72(2):494–508. doi: 10.1016/0042-6822(76)90178-1. [DOI] [PubMed] [Google Scholar]
  34. Ogasawara T., Gotoh B., Suzuki H., Asaka J., Shimokata K., Rott R., Nagai Y. Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J. 1992 Feb;11(2):467–472. doi: 10.1002/j.1460-2075.1992.tb05076.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Palmieri S., Mitchell B. W. Comparison of three velogenic strains of Newcastle disease virus by RNA oligonucleotide fingerprinting. Avian Dis. 1991 Apr-Jun;35(2):384–388. [PubMed] [Google Scholar]
  36. Panigrahy B., Senne D. A., Pearson J. E., Mixson M. A., Cassidy D. R. Occurrence of velogenic viscerotropic Newcastle disease in pet and exotic birds in 1991. Avian Dis. 1993 Jan-Mar;37(1):254–258. [PubMed] [Google Scholar]
  37. Pearson J. E., Senne D. A., Alexander D. J., Taylor W. D., Peterson L. A., Russell P. H. Characterization of Newcastle disease virus (avian paramyxovirus-1) isolated from pigeons. Avian Dis. 1987 Jan-Mar;31(1):105–111. [PubMed] [Google Scholar]
  38. Perdue M. L. Naturally occurring NS gene variants in an avian influenza virus isolate. Virus Res. 1992 May;23(3):223–240. doi: 10.1016/0168-1702(92)90110-u. [DOI] [PubMed] [Google Scholar]
  39. Saiki R. K., Scharf S., Faloona F., Mullis K. B., Horn G. T., Erlich H. A., Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985 Dec 20;230(4732):1350–1354. doi: 10.1126/science.2999980. [DOI] [PubMed] [Google Scholar]
  40. Sakaguchi T., Toyoda T., Gotoh B., Inocencio N. M., Kuma K., Miyata T., Nagai Y. Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology. 1989 Apr;169(2):260–272. doi: 10.1016/0042-6822(89)90151-7. [DOI] [PubMed] [Google Scholar]
  41. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sato H., Oh-hira M., Ishida N., Imamura Y., Hattori S., Kawakita M. Molecular cloning and nucleotide sequence of P, M and F genes of Newcastle disease virus avirulent strain D26. Virus Res. 1987 May;7(3):241–255. doi: 10.1016/0168-1702(87)90031-1. [DOI] [PubMed] [Google Scholar]
  43. Schaper U. M., Fuller F. J., Ward M. D., Mehrotra Y., Stone H. O., Stripp B. R., De Buysscher E. V. Nucleotide sequence of the envelope protein genes of a highly virulent, neurotropic strain of Newcastle disease virus. Virology. 1988 Jul;165(1):291–295. doi: 10.1016/0042-6822(88)90686-1. [DOI] [PubMed] [Google Scholar]
  44. Schloer G. M., Hanson R. P. Relationship of plaque size and virulence for chickens of 14 representative Newcastle disease virus strains. J Virol. 1968 Jan;2(1):40–47. doi: 10.1128/jvi.2.1.40-47.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Schloer G. Antigenic relationships among Newcastle disease virus mutants obtained from laboratory strains and from recent California isolates. Infect Immun. 1974 Oct;10(4):724–732. doi: 10.1128/iai.10.4.724-732.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Senne D. A., Pearson J. E., Miller L. D., Gustafson G. A. Virus isolations from pet birds submitted for importation into the United States. Avian Dis. 1983 Jul-Sep;27(3):731–744. [PubMed] [Google Scholar]
  47. Simmons G. C. The isolation of Newcastle disease virus in Queensland. Aust Vet J. 1967 Jan;43(1):29–30. doi: 10.1111/j.1751-0813.1967.tb04764.x. [DOI] [PubMed] [Google Scholar]
  48. Toyoda T., Sakaguchi T., Hirota H., Gotoh B., Kuma K., Miyata T., Nagai Y. Newcastle disease virus evolution. II. Lack of gene recombination in generating virulent and avirulent strains. Virology. 1989 Apr;169(2):273–282. doi: 10.1016/0042-6822(89)90152-9. [DOI] [PubMed] [Google Scholar]
  49. Toyoda T., Sakaguchi T., Imai K., Inocencio N. M., Gotoh B., Hamaguchi M., Nagai Y. Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology. 1987 May;158(1):242–247. doi: 10.1016/0042-6822(87)90261-3. [DOI] [PubMed] [Google Scholar]
  50. Utterback W. W., Schwartz J. H. Epizootiology of velogenic viscerotropic Newcastle disease in southern California, 1971-1973. J Am Vet Med Assoc. 1973 Nov 1;163(9):1080–1088. [PubMed] [Google Scholar]
  51. Wilson R. A., Perrotta C., Jr, Frey B., Eckroade R. J. An enzyme-linked immunosorbent assay that measures protective antibody levels to Newcastle disease virus in chickens. Avian Dis. 1984 Oct-Dec;28(4):1079–1085. [PubMed] [Google Scholar]
  52. Wobeser G., Leighton F. A., Norman R., Myers D. J., Onderka D., Pybus M. J., Neufeld J. L., Fox G. A., Alexander D. J. Newcastle disease in wild water birds in western Canada, 1990. Can Vet J. 1993 Jun;34(6):353–359. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES